Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo C Chate

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Radiology|April 4, 2020
Coronavirus Disease 2019 Deep Learning Models: Methodologic ConsiderationsAndrew M V Dadário, Joselisa P Q de Paiva, Rodrigo C Chate, et al.
Seminars in Ultrasound, CT, and MR|May 30, 2018
Understanding Lung-RADS 1.0: A Case-Based ReviewMyrna C B Godoy, Erika G L C Odisio, Jeremy J Erasmus, et al.
Journal of Surgical Oncology|March 25, 2018
What happens to the pleural space affected by malignant effusion after bedside pleurodesis?Pedro H X N de Araujo, Ricardo M Terra, Thiago da Silva Santos, et al.
JTO Clinical and Research Reports|February 9, 2026
Pathologic Responses to Stereotactic Ablative Radiotherapy in Combination With Nivolumab for Early Stage NSCLC: A Phase 2 StudyGustavo Schvartsman, Yasmin M Amirato, Frederico Monfardini, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Radiology|April 4, 2020
Coronavirus Disease 2019 Deep Learning Models: Methodologic ConsiderationsAndrew M V Dadário, Joselisa P Q de Paiva, Rodrigo C Chate, et al.
Seminars in Ultrasound, CT, and MR|May 30, 2018
Understanding Lung-RADS 1.0: A Case-Based ReviewMyrna C B Godoy, Erika G L C Odisio, Jeremy J Erasmus, et al.
Journal of Surgical Oncology|March 25, 2018
What happens to the pleural space affected by malignant effusion after bedside pleurodesis?Pedro H X N de Araujo, Ricardo M Terra, Thiago da Silva Santos, et al.
JTO Clinical and Research Reports|February 9, 2026
Pathologic Responses to Stereotactic Ablative Radiotherapy in Combination With Nivolumab for Early Stage NSCLC: A Phase 2 StudyGustavo Schvartsman, Yasmin M Amirato, Frederico Monfardini, et al.
Pageof 1